{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T11:51:41Z","timestamp":1712663501159},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.cld.2008.09.005","type":"journal-article","created":{"date-parts":[[2009,1,15]],"date-time":"2009-01-15T09:26:41Z","timestamp":1232011601000},"page":"87-93","source":"Crossref","is-referenced-by-count":7,"title":["The Role of Anti-Fibrinolytics, rFVIIa and Other Pro-Coagulants: Prophylactic Versus Rescue?"],"prefix":"10.1016","volume":"13","author":[{"given":"Neeral L.","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen H.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl L.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2008.09.005_bib1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00062752-200011000-00015","article-title":"New products for managing inhibitors to coagulation factors: a focus on recombinant factor VIIa concentrate","volume":"7","author":"Kessler","year":"2000","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.cld.2008.09.005_bib2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(88)90259-0","article-title":"Successful use of recombinant factor VIIa in patient with severe haemophilia a during synovectomy","volume":"2","author":"Hedner","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2008.09.005_bib3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1160\/TH05-01-0032","article-title":"Recombinant factor VIIa. An update on its clinical use","volume":"93","author":"Franchini","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cld.2008.09.005_bib4","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0016-5085(97)70013-1","article-title":"Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study","volume":"113","author":"Bernstein","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.09.005_bib5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/gast.2002.34164","article-title":"Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy","volume":"123","author":"Jeffers","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.09.005_bib6","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1053\/j.gastro.2004.07.015","article-title":"Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.09.005_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1542-3565(03)00295-7","article-title":"Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices","volume":"2","author":"Romero-Castro","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2008.09.005_bib8","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/hep.22216","article-title":"Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial","volume":"47","author":"Bosch","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.09.005_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/jlts.2003.50017","article-title":"Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy","volume":"9","author":"Shami","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2008.09.005_bib10","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/lt.20447","article-title":"The role of recombinant factor VIIa in liver transplantation","volume":"11","author":"Porte","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2008.09.005_bib11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/lt.20458","article-title":"Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease","volume":"11","author":"Planinsic","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2008.09.005_bib12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/clpt.1994.80","article-title":"Pharmacokinetics and pharmacodynamics of recombinant factor VIIa","volume":"55","author":"Lindley","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cld.2008.09.005_bib13","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/lt.20470","article-title":"Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation","volume":"11","author":"Lodge","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2008.09.005_bib14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00001721-200009000-00010","article-title":"Recombinant factor VIIa treatment of bleeding associated with acute renal failure","volume":"11","author":"Moisescu","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.cld.2008.09.005_bib15","first-page":"466A","article-title":"Factor VII versus FFP for bleeding associated with percutaneous liver biopsy: a cost-effectiveness evaluation. [Poster]. American Association for the Study of Liver Diseases, 57th Annual Meeting. Boston MA","volume":"44","author":"Northup Pg","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.09.005_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM199807233390407","article-title":"Hemostatic drugs","volume":"339","author":"Mannucci","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2008.09.005_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2036.2006.02730.x","article-title":"The efficacy and safety of epsilon-aminocaproic acid treatment in patients with cirrhosis and hyperfibrinolysis","volume":"23","author":"Gunawan","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2008.09.005_bib18","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0140-6736(87)91190-1","article-title":"Effect of aprotinin on need for blood transfusion after repeat open-heart surgery","volume":"2","author":"Royston","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2008.09.005_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/lt.20275","article-title":"Antifibrinolytics in orthotopic liver transplantation: current status and controversies","volume":"11","author":"Xia","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2008.09.005_bib20","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(00)02111-5","article-title":"Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT study group","volume":"355","author":"Porte","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2008.09.005_bib21","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.510260509","article-title":"The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study","volume":"26","author":"Garcia-Huete","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.09.005_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1213\/00000539-200007000-00006","article-title":"Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation","volume":"91","author":"Dalmau","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1016\/j.cld.2008.09.005_bib23","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1056\/NEJMra067742","article-title":"Prevention and treatment of major blood loss","volume":"356","author":"Mannucci","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2008.09.005_bib24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1096-8652(199602)51:2<168::AID-AJH14>3.0.CO;2-E","article-title":"Safety and efficacy of purified factor IX concentrate and antifibrinolytic agents for dental extractions in hemophilia B","volume":"51","author":"Djulbegovic","year":"1996","journal-title":"Am\u00a0J Hematol"},{"key":"10.1016\/j.cld.2008.09.005_bib25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1378\/chest.100.3.847","article-title":"Tranexamic acid treatment of hemothorax in two patients with malignant mesothelioma","volume":"100","author":"De Boer","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.cld.2008.09.005_bib26","first-page":"577","article-title":"Biliary tract surgery and cirrhosis: a critical combination","volume":"90","author":"Schwartz","year":"1981","journal-title":"Surgery"},{"key":"10.1016\/j.cld.2008.09.005_bib27","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1097\/01.CCM.0000287592.94554.5F","article-title":"Intensive care of patients with acute liver failure: recommendations of the U.S. acute liver failure study group","volume":"35","author":"Stravitz","year":"2007","journal-title":"Crit Care Med"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326108000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326108000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T09:04:19Z","timestamp":1558083859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326108000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S1089326108000949"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2008.09.005","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}